Annual Report

Overview

The report describes Neogen's record fiscal 2013 performance, with total revenues of $207,528 thousand, up 13% from 2012, and net income attributable to Neogen of $27,190 thousand. Food Safety and Animal Safety revenues reached $106,158 thousand and $101,370 thousand, respectively. The company expanded through acquisitions of Macleod Pharmaceuticals, Scidera Genomics and SyrVet, while international revenue represented 40.1% of consolidated revenues.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2013
Period: Ends 31 May 2013
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services